论文部分内容阅读
哮喘患者急性支气管痉挛有潜在的生命危险,院前医护人员要有一定的认识并给予处治。既往的10～15年内,皮下注射肾上素常作为治疗的首选药物。在急诊科(ED),β_2受体激动剂显示出与皮下注射肾上腺素相同的效果。为了比较两种药物对哮喘患者的作用和不良反应,作者对154例成人哮喘患者进行该项研究。 方法年龄18～50岁,有呼吸急促和喘息病史。经鼻导管吸氧4L/min,随机分为3组。第1组53例(34%)。皮下注射1:1000肾上腺素3ml;第3组49例(32%),雾化吸入2.5mg,二羟苯基异氨基乙醇盐溶液
Acute bronchospasm in asthmatic patients is potentially life-threatening, and hospital staff must have some knowledge and treatment. Past 10 to 15 years, subcutaneous injection of suprarenal as the drug of choice for treatment. In ED, beta 2 agonists showed the same effect as subcutaneous injection of epinephrine. To compare the effects and side effects of two drugs on asthma patients, the authors conducted the study in 154 adults with asthma. Methods Age 18 to 50 years old, with shortness of breath and wheezing history. Nasal catheter oxygen 4L / min, were randomly divided into 3 groups. Group 1 53 cases (34%). Subcutaneous injection of 1: 1000 epinephrine 3ml; group 3 49 cases (32%), inhalation of inhalation 2.5mg, dihydroxyphenyl isethionate solution